GALVANI, Elena
 Distribuzione geografica
Continente #
EU - Europa 42
AS - Asia 19
NA - Nord America 14
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 78
Nazione #
DE - Germania 13
IT - Italia 12
US - Stati Uniti d'America 12
CN - Cina 7
IE - Irlanda 6
IN - India 5
RU - Federazione Russa 3
FR - Francia 2
HU - Ungheria 2
AU - Australia 1
BO - Bolivia 1
CA - Canada 1
EG - Egitto 1
ES - Italia 1
GB - Regno Unito 1
ID - Indonesia 1
KR - Corea 1
KZ - Kazakistan 1
MX - Messico 1
PT - Portogallo 1
SG - Singapore 1
TR - Turchia 1
TW - Taiwan 1
UA - Ucraina 1
VN - Vietnam 1
Totale 78
Città #
Dublin 6
Parma 5
Beijing 3
Waterville 3
Concord 2
Gladbeck 2
Hangzhou 2
Szeged 2
Vadodara 2
Bangalore 1
Boardman 1
Brooklyn 1
Chandigarh 1
Cochabamba 1
Columbus 1
Dallas 1
East Syracuse 1
Edmonton 1
Garching 1
Genova 1
Hanoi 1
London 1
Madrid 1
Milan 1
Modena 1
Monterrey 1
Moscow 1
Pittsburgh 1
Porto 1
Roda 1
Rome 1
Shanghai 1
Taipei 1
Taraz 1
Viernheim 1
Washington 1
Totale 54
Nome #
null, file e177fbc4-3a65-50b0-e053-d805fe0adaee 28
Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer, file e177fbc4-374a-50b0-e053-d805fe0adaee 26
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines, file e177fbc4-3e0a-50b0-e053-d805fe0adaee 19
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones. (Cavazzoni and Bonelli co-first authors), file e177fbc4-2810-50b0-e053-d805fe0adaee 4
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification, file e177fbc4-3c48-50b0-e053-d805fe0adaee 1
Totale 78
Categoria #
all - tutte 125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 2 0 0 0 0 0
2022/20238 0 0 0 0 0 1 0 0 6 0 1 0
2023/20246 0 0 0 1 0 0 2 1 0 1 1 0
Totale 78